OGRD Alliance · Powered by STIP™
Building the operating architecture for patient-specific biotechnology.
PLPC™ Platform is a proprietary biotechnology infrastructure that connects structural immunobiology, patient-specific execution, localized medical devices, precision healthspan systems and an AI-ready immunobiological intelligence graph.
PLPC™ Platform builds the architectures. ONCOVIX™ translates them into patient-specific execution. STIP™ turns every execution into connected intelligence.
One IP core. Multiple execution engines. Compounding platform value.
PLPC™ Platform is designed as a multivertical biotechnology infrastructure. The products create market access. The executions generate evidence. The graph compounds platform value.
Clinical Translation
ONCOVIX™ · PLPC-DB™
Patient-specific execution, longitudinal evidence and biomedical upside.
Localized Devices
APHELAR™
Device-led market access and localized interface development.
Precision Healthspan
ABIMPROSYC™
Commercial entry through defense, recovery, vitality and performance.
Intelligence & Moat
STIP™ · FSI™
Connected evidence, comparability, diligence and BioAI optionality.
Beyond single-target biotechnology
PLPC™ Platform proposes a different category: Structural Immunobiological Intelligence. It studies how receptors, membranes, proteins and longitudinal evidence are organized as a system.
Conventional Biotechnology Asks...
- What molecule is present?
- What receptor is expressed?
- What biomarker changed?
- What product was administered?
PLPC™ Platform Asks...
- How is the molecular system organized?
- Is the receptor structurally and functionally integrated?
- What trajectory and context produced the change?
- Which version, lot, protocol and follow-up were involved?
Eight Foundational Mechanisms (M1–M8)
A framework for scientific interrogation, architecture design and evidence organization.
Scientific Validation & Research
Backed by over 11 years of structural immunology development under Dr. Ramón Gutiérrez.
ONCOVIX™: The Patient-Specific Execution Pathway
ONCOVIX™ is where PLPC™ Platform moves from architecture to individual execution. It is the operational layer through which clinical complexity, biological context, conventional treatment, functional status and biomarkers are evaluated around one person.
STIP™: The Immunobiological Intelligence Graph
STIP™ is the intelligence infrastructure that makes PLPC™ operational, auditable and scalable. It connects product identity, formulation, lot history, protocol, baseline, biomarkers, functional execution, reports, evidence packages and claims control.
The graph is the asset: connected evidence compounds in value over time.
Enter the STIP™ Graph
Differentiated Routes to Market
Common architecture does not mean interchangeable products. Each engine opens specialized, defensible commercial pathways.
APHELAR™ · Localized Medical Devices
Translates PLPC™ Platform principles into localized medical-device and interface configurations (IO, TOL, REG). Each product preserves its own intended use, material specifications, quality controls and territorial documentation.
Explore APHELAR™ Pathway →ABIMPROSYC™ · Precision Healthspan
The functional nutraceutical family of PLPC™ Platform. Formulated around specific functional territories: T-Defense™, Regenera™, Vitalis™ and SPORT™, backed by Whole-Matrix evaluation and STIP™ traceability.
Discover ABIMPROSYC™ →High-technology positioning requires high-discipline governance.
PLPC™ Platform separates platform from product, program from candidate, mechanism from outcome, evidence from inference, and current capability from future optionality.
Scientific & Platform Overviews
Explore the documentary and regulatory backbone of the PLPC™ ecosystem through our official media library.
Video 1 – "PLPC™ Platform Overview"
Introduces the complete PLPC™ ecosystem as a unified scientific and regulatory platform. Summarizes eleven years of development and its transition from R&D to a transaction-ready asset.
Video 2 – "PLPC-DB™: Cancer Personalized Immunotherapy"
Depicts how PLPC-DB™ teaches the immune system to recognize and remember tumor cells without inflammation or toxicity. Explains "immunology without storm" in precision oncology.
Video 3 – "STIP™ Regulatory Engine"
Presents the Structured Traceability & Immunophenotypic Platform (STIP™). Illustrates data capture, audit trails, and CTD 5.3 outputs confirming full regulatory readiness.
Latest Platform Developments
Press Release
ABIMPROSYC™ Launches Functional Architecture
The nutraceutical line validated through STIP™ extends structural immunology logic to wellness and longevity.
Read More →R&D Update
APHELAR™ Localized Interface Configurations
New medical device architecture preserves intended use and material specifications across multiple territories.
Read More →Partnerships
OGRD Alliance Expands Investor Access
New data room availability for territorial licensing, vertical partnerships, and joint development programs.
Access Data Room →Partner in the future of structural immunobiological intelligence.
Multiple entry points into one platform architecture: territorial licensing, vertical partnerships, joint development and Data Room access.